Ammas Biomedical

Ammas Biomedical is a biotechnology company specializing in the development of advanced optical imaging technologies and metabolic-based therapies for cancer. The company leverages Fluorescence Lifetime Imaging Microscopy (FLIM) and Förster Resonance Energy Transfer (FRET) to perform real-time metabolic profiling of cancer cells. By monitoring metabolic co-factors like NADH and FAD, their platform provides deep insights into the tumor microenvironment and cellular responses to treatment. Ammas Biomedical aims to translate these high-resolution imaging techniques into clinical tools for earlier cancer detection and personalized therapeutic monitoring. Additionally, the company is exploring therapeutic interventions that target the metabolic vulnerabilities of cancer cells identified through their imaging platform. Founded as a spin-off from the University of Virginia, Ammas Biomedical is positioned at the intersection of advanced diagnostics and precision medicine.